Hey @Glenr1975, I hold MAN and am a keen observer of the many...

Hey @Glenr1975, I hold MAN and am a keen observer of the many nearology players in the region such as ASN, CPN, DEV, OAR et al.

At MAN we went through this same thought process of thinking why sell pending the assay results? Then when said assay results came it simply confirmed what the market has already concluded - poor assay results.

[Like MAN, PUR is being pumped by C3 Consortium (Catalyst Hunter - MAN; Next Investor - PUR). They are paid by the companies for ‘marketing’. It’s no secret how C3 operate, what their business model is.]

What investors in these nearology players need to understand is that the risk is higher as the odds of finding similar success is lower. While it’s too early to tell, it may very well be that CHN does indeed have the only mineable resource in the area. CPN was the first, MAN was next and bow it appears PUR may be the third.

I’m not down ramping PUR. The best thing for the nearology players is for one of them to succeed as it will have a positive effect on the share price of the other players.

If I had my time again I would have sold half my holdings in MAN after the drilling results were announced but I did pick up some valuable investing lessons.

Good luck to all PUR holders.